NEW YORK (GenomeWeb News) — Catapult Bio, an Arizona non-profit focused on funding and providing services to regional biotechnology startups, has used a five-year, $14 million grant from the Los Angeles company Abraxis BioScience to fund its official launch.

Catapult Bio, which arose out of the Translational Genome Research Institute’s TGen Accelerators program, is aimed at developing research discoveries into new businesses that accelerate life sciences commercialization.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.